NR 606 Week 8 Final Exam (2025/2026) LATEST |COMPLETE QUESTIONS AND VERIFIED ANSWERS (GRADED A+) DETAILED ANSWERS!!

Stimulant Medications: Methylphenidate -Low risk of adverse effects -Available formulations: • Ritalin - available in immediate release (IR) and extended release (XR) available in beads that may be sprinkled on food for children who cannot swallow pills • Concerta biphasic - combined immediate and delayed release in one medication • Daytrana - patch applied in AM and removed after 9 hour Stimulant Medications: Dexmethylphenidate (Focalin) -Available in IR and ER -More potent than Ritalin -High risk of adverse effects Stimulant Medications: Amphetamine (Adzenys) -available in orally disintegrating ER formula for children who cannot swallow pills -Avoid prescribing when an MAOI has been used within 14 days Stimulant Medications: Dextroamphetamine (Adderall) -Available in IR and extended-release formulations -Often dosed in morning (IR or XR) with an evening or evening prn (IR) dose if med effects diminish prior to end of school, study or the workday -Most abused & diverted prescription stimulant Stimulant Medications: Lisdexamfetamine (Vyvanse) -Biologically inactive until metabolized by the body (Prodrug) -Less abuse & diversion potential than other stimulants -Higher-cost medication Non-stimulant medication: Atomoxetine (Strattera) -Noradrenergic (NRI) -Initial drug of choice for adults with ADHD -no abuse potential -tolerated well when prescribed in BID dosing -appropriate choice for comorbid substance abuse -may augment the effects of antidepressants & antianxiety meds -can be dosed at bedtime if fatigue is noted -unlikely to worsen tics Non-stimulant medication: Clonidine -α 2 agonist • May be taken as monotherapy or with stimulant medications